首页 > 最新文献

Journal of Ayurveda and Integrated Medical Sciences (JAIMS)最新文献

英文 中文
Phytochemical evaluation of Celastrus paniculatus seed oil extracted by a method used by ‘Uraanv’ tribe of Chhattisgarh 用恰蒂斯加尔邦Uraanv部落的方法提取的蛇芹籽油的植物化学评价
Pub Date : 2020-04-25 DOI: 10.21760/jaims.5.2.9
L. Sahu, P. Joshi, O. Rout, A. Sahu
More than 35,000 plant species are being used in various human cultures around the world for medicinal purposes. Medicated oil plays an important role for prevention and cure of diseases in Ayurveda. Celastrus paniculatus seed oil is such wonderful medicinally useful oil. It is commonly known as Black-Oil tree, Intellect tree, Climbing-staff plant and Jyotishmati and “Tree of life” in Ayurveda. It possesses Anti-depressant, Anti-Parkinson, Anti-Alzheimer’s, Neuroprotective, IQ improving activity. In tribal district (Jashpur) of Chhattisgarh, Indian people uses traditional method to extract C. paniculatus oil. It is commonly used by the tribes for the treatment of various diseases like headache, muscular spasm and local inflammations. The present study aim is documentation of traditional method of oil extraction used by ‘Uraanv’ tribe. This paper also dealt with the Physicochemical and qualitative phytochemical evaluation of C. paniculatus seed oil. Oil yield by traditional method was 25%. Carbohydrate, reducing sugar, monosaccharide, protein, amino acid, steroid, flavonoid, alkaloid, fixed oil, phytosterols, saponin, diterpenoid and cardiac glycoside were found in the oil sample.The GC-MS analysis shows the presence of 47 compounds in the oil. These phytochemical might be responsible for the therapeutic effect of C. paniculatsus seed oil.
在世界各地不同的人类文化中,有超过35000种植物被用于医疗目的。药用油在阿育吠陀中起着预防和治疗疾病的重要作用。蛇芹籽油就是这样一种奇妙的药用油。它通常被称为黑油树、智慧树、攀爬之杖植物和阿育吠陀中的Jyotishmati和“生命之树”。具有抗抑郁、抗帕金森、抗阿尔茨海默病、神经保护、提高智商等作用。在恰蒂斯加尔邦(Chhattisgarh)的部落地区(Jashpur),印度人用传统的方法提取金针藤油。它通常被部落用来治疗各种疾病,如头痛、肌肉痉挛和局部炎症。本研究的目的是记录Uraanv部落使用的传统采油方法。本文还对金银花籽油进行了理化和植物化学定性评价。传统方法产油率为25%。油样品中含有碳水化合物、还原糖、单糖、蛋白质、氨基酸、类固醇、类黄酮、生物碱、固定油、植物甾醇、皂苷、二萜和心糖苷。GC-MS分析表明,该油中存在47种化合物。这些植物化学物质可能与芫荽籽油的治疗作用有关。
{"title":"Phytochemical evaluation of Celastrus paniculatus seed oil extracted by a method used by ‘Uraanv’ tribe of Chhattisgarh","authors":"L. Sahu, P. Joshi, O. Rout, A. Sahu","doi":"10.21760/jaims.5.2.9","DOIUrl":"https://doi.org/10.21760/jaims.5.2.9","url":null,"abstract":"More than 35,000 plant species are being used in various human cultures around the world for medicinal purposes. Medicated oil plays an important role for prevention and cure of diseases in Ayurveda. Celastrus paniculatus seed oil is such wonderful medicinally useful oil. It is commonly known as Black-Oil tree, Intellect tree, Climbing-staff plant and Jyotishmati and “Tree of life” in Ayurveda. It possesses Anti-depressant, Anti-Parkinson, Anti-Alzheimer’s, Neuroprotective, IQ improving activity. In tribal district (Jashpur) of Chhattisgarh, Indian people uses traditional method to extract C. paniculatus oil. It is commonly used by the tribes for the treatment of various diseases like headache, muscular spasm and local inflammations. The present study aim is documentation of traditional method of oil extraction used by ‘Uraanv’ tribe. This paper also dealt with the Physicochemical and qualitative phytochemical evaluation of C. paniculatus seed oil. Oil yield by traditional method was 25%. Carbohydrate, reducing sugar, monosaccharide, protein, amino acid, steroid, flavonoid, alkaloid, fixed oil, phytosterols, saponin, diterpenoid and cardiac glycoside were found in the oil sample.The GC-MS analysis shows the presence of 47 compounds in the oil. These phytochemical might be responsible for the therapeutic effect of C. paniculatsus seed oil.","PeriodicalId":153289,"journal":{"name":"Journal of Ayurveda and Integrated Medical Sciences (JAIMS)","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124814630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A Randomized Comparative Clinical Study to evaluate the effect of Bodhi Vruksha Twak Kashaya with Madhu and Guduchi Kashaya in the Management of Vatarakta with special reference to Gouty Arthritis 一项随机对照临床研究,评价菩提法与Madhu法、Guduchi法治疗痛风性关节炎的疗效
Pub Date : 2020-04-25 DOI: 10.21760/jaims.5.2.4
K. Bhavana, C. Umesh, Neelakanta Sajjanar, G. G. Krishna
Background: Vatarakta is a disease which is said to affect the population indulging in sedentary lifestyle. In today’s era the evolution of technology has reached a point where pretty much anything is available at the touch of a button. The lifestyle of today’s population is breeding ground for diseases like Vatarakta. Based on the causes, signs and symptoms, Vatarakta may be correlated to gouty arthritis in contemporary medicine. Gout affects about 2.1 million worldwide. Its prevalence is increasing; moreover it is a potential signal for unrecognized co-morbidities like obesity, diabetes mellitus, hypertension and renal diseases. In India the prevalence of gout is 2-6 per 1000. The purpose of this study is to explore and find out an effective, less expensive, easily available and well accepted drug with minimal or no complications for this dreadful condition. Materials and Methods: 40 patients diagnosed with Vatarakta w.s.r Gouty Arthritis were assigned randomly into 2 groups. Group A, were administered Bodhi Vruksha Twak Kashaya 50ml B.I.D with Madhu and Group B were administered Guduchi Kashaya 50ml B.I.D for a duration of 30 days. Assessment was done on day 0, day 15, day 30, and day 45. Observations and Results: In the present study Group A showed statistical significant results in all the parameters except for Sandhishotha and group B showed statistical significant result in Sandhishoola, Sandhidaha, Sparshasahaishnuta and uric acid levels. Conclusion: Overall result shows patients treated with Guduchi Kashaya showed better results than patients treated with Bodhi Vruksha Twak Kashaya with Madhu in Vatarakta with special reference to Gouty Arthritis.
背景:Vatarakta是一种疾病,据说会影响沉迷于久坐不动生活方式的人群。在当今时代,技术的发展已经达到了一个点,几乎任何东西都可以在触摸一个按钮。当今人口的生活方式是瓦塔拉克塔等疾病的滋生地。根据病因、体征和症状,当代医学认为Vatarakta可能与痛风性关节炎有关。全球约有210万人患有痛风。其流行率正在上升;此外,它是肥胖、糖尿病、高血压和肾脏疾病等未被认识的合并症的潜在信号。在印度,痛风的患病率为每1000人中2-6人。这项研究的目的是探索和找到一种有效的、更便宜的、容易获得的、被广泛接受的药物,这种药物对这种可怕的疾病的并发症最小或没有。材料与方法:将40例诊断为Vatarakta w.s.r痛风性关节炎的患者随机分为两组。A组给予菩提Vruksha Twak Kashaya 50ml B.I.D与Madhu, B组给予Guduchi Kashaya 50ml B.I.D,持续30天。分别于第0天、第15天、第30天和第45天进行评估。观察与结果:在本研究中,A组除Sandhishotha外,其他参数均有统计学意义;B组在Sandhishoola、Sandhidaha、Sparshasahaishnuta和尿酸水平上均有统计学意义。结论:总体结果显示,菩提风沙加摩度治疗痛风性关节炎的疗效优于菩提风沙加摩度治疗痛风性关节炎的疗效。
{"title":"A Randomized Comparative Clinical Study to evaluate the effect of Bodhi Vruksha Twak Kashaya with Madhu and Guduchi Kashaya in the Management of Vatarakta with special reference to Gouty Arthritis","authors":"K. Bhavana, C. Umesh, Neelakanta Sajjanar, G. G. Krishna","doi":"10.21760/jaims.5.2.4","DOIUrl":"https://doi.org/10.21760/jaims.5.2.4","url":null,"abstract":"Background: Vatarakta is a disease which is said to affect the population indulging in sedentary lifestyle. In today’s era the evolution of technology has reached a point where pretty much anything is available at the touch of a button. The lifestyle of today’s population is breeding ground for diseases like Vatarakta. Based on the causes, signs and symptoms, Vatarakta may be correlated to gouty arthritis in contemporary medicine. Gout affects about 2.1 million worldwide. Its prevalence is increasing; moreover it is a potential signal for unrecognized co-morbidities like obesity, diabetes mellitus, hypertension and renal diseases. In India the prevalence of gout is 2-6 per 1000. The purpose of this study is to explore and find out an effective, less expensive, easily available and well accepted drug with minimal or no complications for this dreadful condition. Materials and Methods: 40 patients diagnosed with Vatarakta w.s.r Gouty Arthritis were assigned randomly into 2 groups. Group A, were administered Bodhi Vruksha Twak Kashaya 50ml B.I.D with Madhu and Group B were administered Guduchi Kashaya 50ml B.I.D for a duration of 30 days. Assessment was done on day 0, day 15, day 30, and day 45. Observations and Results: In the present study Group A showed statistical significant results in all the parameters except for Sandhishotha and group B showed statistical significant result in Sandhishoola, Sandhidaha, Sparshasahaishnuta and uric acid levels. Conclusion: Overall result shows patients treated with Guduchi Kashaya showed better results than patients treated with Bodhi Vruksha Twak Kashaya with Madhu in Vatarakta with special reference to Gouty Arthritis.","PeriodicalId":153289,"journal":{"name":"Journal of Ayurveda and Integrated Medical Sciences (JAIMS)","volume":"86 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130678028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative evaluation of efficacy of three different mouthwashes as an adjunct to nonsurgical periodontal therapy - A double blind clinical study 三种不同漱口水作为非手术牙周治疗辅助治疗效果的比较评价-一项双盲临床研究
Pub Date : 2020-04-25 DOI: 10.21760/jaims.5.2.3
Nitin Gorwade, C. Dhalkari, D. G. Pol
Ayurvedic medicine was considered to be world’s oldest medical system, which was originated in India dating back over thousands of years. There was a long history regarding plants for the improvement of dental health and oral hygiene. Dentistry, Herbal Medicine, Periodontitis. Current researches showed that herbal extracts are effective because of the interaction with specific chemical receptors within the body. Nowadays, there has been a sudden increase in the use of herbal extracts or plant products as an alternative approach to modern day medicines. This system originated from Atharvaveda, one of the four Vedas written before 5000 B.C. However its use in dentistry/oral health is very limited. Therefore the present study was done to evaluate the effeicacy of Triphala and Bakul in comparison with chlorhexidine as an adjunct to non surgical periodontal therapy.
阿育吠陀医学被认为是世界上最古老的医疗体系,它起源于印度,可以追溯到几千年前。植物用于改善牙齿健康和口腔卫生的历史很长。牙科,草药,牙周炎。目前的研究表明,草药提取物与体内特定化学受体的相互作用是有效的。如今,草药提取物或植物产品的使用突然增加,作为现代药物的替代方法。这个系统起源于阿达瓦吠陀,它是公元前5000年之前写的四大吠陀之一。然而,它在牙科/口腔健康方面的应用非常有限。因此,本研究是为了评估Triphala和Bakul与氯己定作为非手术牙周治疗辅助治疗的效果。
{"title":"Comparative evaluation of efficacy of three different mouthwashes as an adjunct to nonsurgical periodontal therapy - A double blind clinical study","authors":"Nitin Gorwade, C. Dhalkari, D. G. Pol","doi":"10.21760/jaims.5.2.3","DOIUrl":"https://doi.org/10.21760/jaims.5.2.3","url":null,"abstract":"Ayurvedic medicine was considered to be world’s oldest medical system, which was originated in India dating back over thousands of years. There was a long history regarding plants for the improvement of dental health and oral hygiene. Dentistry, Herbal Medicine, Periodontitis. Current researches showed that herbal extracts are effective because of the interaction with specific chemical receptors within the body. Nowadays, there has been a sudden increase in the use of herbal extracts or plant products as an alternative approach to modern day medicines. This system originated from Atharvaveda, one of the four Vedas written before 5000 B.C. However its use in dentistry/oral health is very limited. Therefore the present study was done to evaluate the effeicacy of Triphala and Bakul in comparison with chlorhexidine as an adjunct to non surgical periodontal therapy.","PeriodicalId":153289,"journal":{"name":"Journal of Ayurveda and Integrated Medical Sciences (JAIMS)","volume":"89 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114866588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A controlled clinical study to evaluate the efficacy of Janu Basti and Asthi Shrinkhala in management of Janusandhigata Vata w.s.r to Osteoarthritis 评价Janu Basti和Asthi Shrinkhala治疗Janu和higata Vata w.s r骨关节炎的对照临床研究
Pub Date : 2020-04-25 DOI: 10.21760/jaims.5.2.2
Rakesh Kudari, G. Krishna G, Sowmyashree U.P., U. C.
Background : Sandhigata Vata is characterized by Shoola (pain), Shopha (swelling) and restricted movement of affected joints. Osteoarthritis is characterized by inflammation of joints, marked by progressive cartilage damage as a result of age related degenerative change or trauma. Sandhigata Vata correlates with Osteoarthritis. Objectives - The present study was intended to evaluate and compare the efficacy of Asthishrinkhala (Trial drug) and Glucosamine sulfate (Control drug) in Janusandhigatavata w.s.r to Osteoarthritis. Materials and Method - 40 subjects diagnosed with Janusandhigatavata were randomly assigned into two equal groups comprising of 20 subjects each. Subjects of Group A received Janubasti with Mahavishagarbha Taila and Tab. Glucosamine sulfate 500mg 1 T.I.D after food and subjects of Group B received Janubasti with Mahavishagarbha Taila and Tab. Asthishrinkhala 500mg 1 T.I.D after food for a duration of 30 days. Observation and Results - In the present study, Asthishrinkhala and Glucosamine sulfate both were beneficial in reducing the symptoms of Janu Sandhigata Vata. On comparison between the groups, Glucosamine sulfate was more in beneficial in reducing the symptom of Janu Sandhigata Vata compared to Asthishrinkhala. However there was a statistically non significant result between groups, overall the subjects on glucosamine sulfate expressed greater benefit compared to Asthishrinkhala. Conclusion - Both the drugs were beneficial in managing the symptoms of Sandigatavata, but overall the subjects treated with glucosamine sulfate expressed greater benefits compared to subjects treated with Asthishrinkhala.
背景:腰痛症的特征是受影响关节的Shoola(疼痛)、Shopha(肿胀)和活动受限。骨关节炎的特征是关节炎症,其特征是由于年龄相关的退行性变化或创伤导致软骨损伤。Sandhigata Vata与骨关节炎有关。目的:本研究旨在评价和比较在Janusandhigatavata w.s.r治疗骨关节炎中的asasthishrinkhala(试验药物)和Glucosamine sulfate(对照药物)的疗效。材料与方法:40例诊断为Janusandhigatavata的受试者随机分为两组,每组20例。A组患者接受大毗沙迦巴泰和泰布联合治疗。硫酸氨基葡萄糖500mg,餐后1次服用,B组患者联合大维沙迦巴泰和泰布治疗。饭后1次,每次服用500mg,持续30天。观察与结果:本研究中,阿喘士林克罗和硫酸氨基葡萄糖均可有效减轻麻风病的症状。在组间比较中,硫酸氨基葡萄糖对减轻小腹病症状的作用优于阿什什林卡罗。然而,组间结果无统计学意义,总体而言,硫酸氨基葡萄糖组比阿什什林卡罗组获益更大。结论:这两种药物都有利于控制Sandigatavata的症状,但总的来说,用硫酸氨基葡萄糖治疗的受试者比用哮喘治疗的受试者表现出更大的益处。
{"title":"A controlled clinical study to evaluate the efficacy of Janu Basti and Asthi Shrinkhala in management of Janusandhigata Vata w.s.r to Osteoarthritis","authors":"Rakesh Kudari, G. Krishna G, Sowmyashree U.P., U. C.","doi":"10.21760/jaims.5.2.2","DOIUrl":"https://doi.org/10.21760/jaims.5.2.2","url":null,"abstract":"Background : Sandhigata Vata is characterized by Shoola (pain), Shopha (swelling) and restricted movement of affected joints. Osteoarthritis is characterized by inflammation of joints, marked by progressive cartilage damage as a result of age related degenerative change or trauma. Sandhigata Vata correlates with Osteoarthritis. Objectives - The present study was intended to evaluate and compare the efficacy of Asthishrinkhala (Trial drug) and Glucosamine sulfate (Control drug) in Janusandhigatavata w.s.r to Osteoarthritis. Materials and Method - 40 subjects diagnosed with Janusandhigatavata were randomly assigned into two equal groups comprising of 20 subjects each. Subjects of Group A received Janubasti with Mahavishagarbha Taila and Tab. Glucosamine sulfate 500mg 1 T.I.D after food and subjects of Group B received Janubasti with Mahavishagarbha Taila and Tab. Asthishrinkhala 500mg 1 T.I.D after food for a duration of 30 days. Observation and Results - In the present study, Asthishrinkhala and Glucosamine sulfate both were beneficial in reducing the symptoms of Janu Sandhigata Vata. On comparison between the groups, Glucosamine sulfate was more in beneficial in reducing the symptom of Janu Sandhigata Vata compared to Asthishrinkhala. However there was a statistically non significant result between groups, overall the subjects on glucosamine sulfate expressed greater benefit compared to Asthishrinkhala. Conclusion - Both the drugs were beneficial in managing the symptoms of Sandigatavata, but overall the subjects treated with glucosamine sulfate expressed greater benefits compared to subjects treated with Asthishrinkhala.","PeriodicalId":153289,"journal":{"name":"Journal of Ayurveda and Integrated Medical Sciences (JAIMS)","volume":"64 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128904084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A comparative clinical study to evaluate the efficacyof Ashwagandha Ghrita on Growth andDevelopment of Infants 评价Ashwagandha Ghrita对婴儿生长发育影响的比较临床研究
Pub Date : 2020-02-28 DOI: 10.21760/jaims.5.1.7
Koushik Baishya, R. Sharma, Vinod Kumar
Introduction: Growth and development are unique characteristics of children. Growth is defined asan increase in the size of an individual due to increase in number and size of the cells, wheredevelopment refers to qualitative and quantitative changes and acquisition of a variety ofcompetencies for functioning optimally in a social milieu. The present study has been planned toevaluate the effect of Ashwagandhaghrita on physical growth and development of infants. Aims andobjectives: To study the efficacy of Ashwagandha Ghrita on Growth and development of infants, interms of change occurred in anthropometry and milestones during the study period. Materials andmethods: The study was conducted on 40 healthy infants for a period of 12 weeks and a caseperforma was filled with the data obtained by interrogation, physical examination and collection ofdetails of each child. Results: Ashwagandha Ghrita showed better effect on physical growth in termsof increment in weight, head circumference, chest circumference, mid arm circumference, crown toheel length as well as early significant achievement of developmental milestones compared to controlgroup. Conclusion: Ashwagandha Ghrita has proved to be beneficial on Growth and Development ofinfants.
导读:生长发育是儿童独有的特征。生长被定义为由于细胞数量和大小的增加而导致的个体尺寸的增加,其中发展指的是定性和定量的变化以及在社会环境中发挥最佳功能的各种能力的获得。本研究旨在评价Ashwagandhaghrita对婴儿身体生长发育的影响。目的:从人体测量学的变化和研究期间的里程碑角度,研究Ashwagandha Ghrita对婴儿生长发育的影响。材料与方法:选取健康婴儿40例为研究对象,为期12周,通过询问、体格检查和收集每个婴儿的详细资料,填写一份病例表。结果:与对照组相比,Ashwagandha Ghrita在体重、头围、胸围、中臂围、冠跟长以及早期显著发育里程碑的实现方面对身体生长有更好的影响。结论:枳实对婴儿生长发育有一定的促进作用。
{"title":"A comparative clinical study to evaluate the efficacy\u0000of Ashwagandha Ghrita on Growth and\u0000Development of Infants","authors":"Koushik Baishya, R. Sharma, Vinod Kumar","doi":"10.21760/jaims.5.1.7","DOIUrl":"https://doi.org/10.21760/jaims.5.1.7","url":null,"abstract":"Introduction: Growth and development are unique characteristics of children. Growth is defined as\u0000an increase in the size of an individual due to increase in number and size of the cells, where\u0000development refers to qualitative and quantitative changes and acquisition of a variety of\u0000competencies for functioning optimally in a social milieu. The present study has been planned to\u0000evaluate the effect of Ashwagandhaghrita on physical growth and development of infants. Aims and\u0000objectives: To study the efficacy of Ashwagandha Ghrita on Growth and development of infants, in\u0000terms of change occurred in anthropometry and milestones during the study period. Materials and\u0000methods: The study was conducted on 40 healthy infants for a period of 12 weeks and a case\u0000performa was filled with the data obtained by interrogation, physical examination and collection of\u0000details of each child. Results: Ashwagandha Ghrita showed better effect on physical growth in terms\u0000of increment in weight, head circumference, chest circumference, mid arm circumference, crown to\u0000heel length as well as early significant achievement of developmental milestones compared to control\u0000group. Conclusion: Ashwagandha Ghrita has proved to be beneficial on Growth and Development of\u0000infants.","PeriodicalId":153289,"journal":{"name":"Journal of Ayurveda and Integrated Medical Sciences (JAIMS)","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123321519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative clnical study on the therapeutic effect ofSaraswatharista and Jaladhara in Nidranasha w.s.r. toInsomnia 菝葜与贾拉达拉治疗失眠的临床比较研究
Pub Date : 2020-02-28 DOI: 10.21760/jaims.5.1.6
Shiddanagouda K. B., K. Roy
Nidra is considered as one among the Trayoupasthambha[1] which is very essential to lead happy andhealthy life. In present era because of stressful lifestyle many people suffering from one or the otherpsychosomatic illnesses, among that insomnia is the most common health problem which affects thefunctions of central nervous system and even other systems. Around 9% of general population aresuffering from insomnia, around 28% of people suffering from initiation and maintenance of sleep. Atpresent the medical management of insomnia includes different variety of benzodiazepines’ whichcauses various toxic effect and also drug dependency. For this one can find out the best remedies inAyurvedic system of medicine, for the treatment of this disease. Saraswatharista[2] is one of the bestShamana medicine with Bramhi Panchanga as main ingredient, having Rasayana effect as well asproperties which can cure the diseases like Unmada, Mada, Apasmara as both Shareerika andManasika Vyadhi are inter-related.[6] And Jaladhara is very safe, effective, readily available and costeffective without any side effect which mainly having Aaswasahara[4] and Nidrajanana action hence,present clinical trial is planned to compare the therapeutic effect of Saraswatharista and Jaladhara inNidranasha with special reference to Insomnia is undertaken.
Nidra被认为是Trayoupasthambha之一[1],这对于过上幸福健康的生活至关重要。在当今时代,由于紧张的生活方式,许多人患有这样或那样的心身疾病,其中失眠是最常见的健康问题,影响中枢神经系统甚至其他系统的功能。大约9%的普通人群患有失眠症,大约28%的人患有开始和维持睡眠。目前失眠的医学治疗包括不同种类的苯二氮卓类药物,这些药物引起各种毒性作用和药物依赖性。为此,人们可以在阿育吠陀医学体系中找到治疗这种疾病的最佳方法。Saraswatharista[2]是最好的萨满药之一,以梵天Panchanga为主要成分,具有Rasayana效果以及可以治疗Unmada, Mada, Apasmara等疾病的特性,因为Shareerika和manasika Vyadhi都是相互关联的。[6]Jaladhara是一种非常安全、有效、易得且无副作用的药物,主要具有Aaswasahara[4]和Nidrajanana的作用,因此,本临床试验计划比较Saraswatharista和Jaladhara inNidranasha的治疗效果,并特别针对失眠进行研究。
{"title":"Comparative clnical study on the therapeutic effect of\u0000Saraswatharista and Jaladhara in Nidranasha w.s.r. to\u0000Insomnia","authors":"Shiddanagouda K. B., K. Roy","doi":"10.21760/jaims.5.1.6","DOIUrl":"https://doi.org/10.21760/jaims.5.1.6","url":null,"abstract":"Nidra is considered as one among the Trayoupasthambha[1] which is very essential to lead happy and\u0000healthy life. In present era because of stressful lifestyle many people suffering from one or the other\u0000psychosomatic illnesses, among that insomnia is the most common health problem which affects the\u0000functions of central nervous system and even other systems. Around 9% of general population are\u0000suffering from insomnia, around 28% of people suffering from initiation and maintenance of sleep. At\u0000present the medical management of insomnia includes different variety of benzodiazepines’ which\u0000causes various toxic effect and also drug dependency. For this one can find out the best remedies in\u0000Ayurvedic system of medicine, for the treatment of this disease. Saraswatharista[2] is one of the best\u0000Shamana medicine with Bramhi Panchanga as main ingredient, having Rasayana effect as well as\u0000properties which can cure the diseases like Unmada, Mada, Apasmara as both Shareerika and\u0000Manasika Vyadhi are inter-related.[6] And Jaladhara is very safe, effective, readily available and cost\u0000effective without any side effect which mainly having Aaswasahara[4] and Nidrajanana action hence,\u0000present clinical trial is planned to compare the therapeutic effect of Saraswatharista and Jaladhara in\u0000Nidranasha with special reference to Insomnia is undertaken.","PeriodicalId":153289,"journal":{"name":"Journal of Ayurveda and Integrated Medical Sciences (JAIMS)","volume":"5 3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123529505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A study of Radiological changes in Janu Sandhiin Amavata 亚努桑德希因阿玛瓦塔的放射学变化研究
Pub Date : 2020-02-28 DOI: 10.21760/jaims.5.1.5
Wasu Isha Pradeep, Choudhari Vinod Mahadevrao
Aim - To study radiological changes in Janu Sandhi due to Amavata. Objectives - 1) To study aboutJanu Sandhi and Knee Joint, 2) To study about Amavata and Rheumatoid Arthritis. Observation - The7 diagnostic criteria according to American College of Rheumatology, epidemiology and genetics,radiological evaluation is one of them, for knee joint - soft tissue swelling, periarticular osteoporosis,joint space reduction, osteophytes, dislocation of joints, secondary eburnation, pseudocytes,periosteal new bone formation, bone erosion is seen. In radiological changes, soft tissue swelling, jointspace reduction and osteophytes is found in 80% patients, periarticular osteoporosis is found inalmost 90% patient. Conclusion - Female are more prone to radiological changes in knee jointaffected by Amavata than male. Also age group of 41-50 yrs are more affected and Vata-Kapha DehajPrakruti people has more radiological changes. This is helpful to find out the extent of progression ofdisease in stages of disease and treatment of disease.
目的:研究阿玛瓦塔引起的Janu Sandhi放射学变化。目的:1)研究janu Sandhi与膝关节的关系;2)研究Amavata与类风湿关节炎的关系。观察-根据美国风湿病学会、流行病学和遗传学的7个诊断标准,影像学评价是其中之一,对于膝关节-软组织肿胀、关节周围骨质疏松、关节间隙缩小、骨赘、关节脱位、继发性灼烧、假细胞、骨膜新骨形成、骨侵蚀可见。在影像学改变中,80%的患者发现软组织肿胀、关节间隙缩小和骨赘,近90%的患者发现关节周围骨质疏松。结论:与男性相比,女性更容易出现Amavata所致的膝关节放射学改变。41-50岁年龄组受影响更大,Vata-Kapha DehajPrakruti人群有更多的放射学变化。这有助于了解疾病各阶段的进展程度和疾病的治疗。
{"title":"A study of Radiological changes in Janu Sandhi\u0000in Amavata","authors":"Wasu Isha Pradeep, Choudhari Vinod Mahadevrao","doi":"10.21760/jaims.5.1.5","DOIUrl":"https://doi.org/10.21760/jaims.5.1.5","url":null,"abstract":"Aim - To study radiological changes in Janu Sandhi due to Amavata. Objectives - 1) To study about\u0000Janu Sandhi and Knee Joint, 2) To study about Amavata and Rheumatoid Arthritis. Observation - The\u00007 diagnostic criteria according to American College of Rheumatology, epidemiology and genetics,\u0000radiological evaluation is one of them, for knee joint - soft tissue swelling, periarticular osteoporosis,\u0000joint space reduction, osteophytes, dislocation of joints, secondary eburnation, pseudocytes,\u0000periosteal new bone formation, bone erosion is seen. In radiological changes, soft tissue swelling, joint\u0000space reduction and osteophytes is found in 80% patients, periarticular osteoporosis is found in\u0000almost 90% patient. Conclusion - Female are more prone to radiological changes in knee joint\u0000affected by Amavata than male. Also age group of 41-50 yrs are more affected and Vata-Kapha Dehaj\u0000Prakruti people has more radiological changes. This is helpful to find out the extent of progression of\u0000disease in stages of disease and treatment of disease.","PeriodicalId":153289,"journal":{"name":"Journal of Ayurveda and Integrated Medical Sciences (JAIMS)","volume":"140 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116905233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An open labeled clinical trail on the effect of Vrikshamlain Sthaulya (obesity) w.s.r to hyperlipidaemia 一项开放标签的临床试验,研究肥胖药对高脂血症的影响
Pub Date : 2020-02-28 DOI: 10.21760/jaims.5.1.4
Ishwarayya S Mathapati, M. R.
Obesity is one of the leading cause for more than 53 diseases and in India around 30 million peoplesare suffering with Sthaulya (obesity), individual habits with stressful life, wrong dietary habits andsedentary life is the main cause of disease and no satisfactory treatment is available in conventionalsystem. Hence there is need explore alternative system of Indian medicine like Ayurveda for thebenefits of sufferers Ayurveda dealt this disease as Sthaulya (obesity) under Medoroga (Adipose tissuedisorder) and many treatment modalities have been explained number of drugs in Brahatrayi(Charaka, Sushruta and Vagbhat) were cited Bhavamishra was the author of Bhavaprakash Nighantu(Lexicon) which is one of the Laghutrayis (Sharanghadara, Madhavanidhana and Bhavaprakash) text ishighlighted with Karmaoushadi (action based drug) such as Amradi Phala Varga explained Vrikshamlaconsidered as drug index of Ayurveda, thus present study was designed to screen the drug withproperties of Kapha Medohara (ability to reduce Kapha and Fat), Medorogahara (reduces Adiposetissue), Sthaulyanashaka (Anti obesity) and Karshyakara (ability to make lean) from BhavaprakashaNighantu in Ayurveda.
肥胖是超过53种疾病的主要原因之一,在印度,大约有3000万人患有Sthaulya(肥胖),压力生活的个人习惯,错误的饮食习惯和久坐不动的生活是导致疾病的主要原因,在传统系统中没有令人满意的治疗方法。因此,有必要探索印度医学的替代系统,如阿育吠陀,以患者的利益。阿育吠陀将这种疾病作为肥胖(肥胖)在Medoroga(脂肪组织紊乱)下,许多治疗方式已经得到解释,许多药物在Brahatrayi(Charaka, Sushruta和Vagbhat)被引用。Bhavamishra是Bhavaprakash Nighantu(词典)的作者,这是Laghutrayis (Sharanghadara)之一。如Amradi Phala Varga将vrikshamlaca解释为阿育吠陀的药物指数,因此本研究旨在筛选阿育吠陀BhavaprakashaNighantu中具有Kapha Medohara(减少Kapha和脂肪的能力),Medorogahara(减少脂肪组织),Sthaulyanashaka(抗肥胖)和Karshyakara(制造瘦的能力)特性的药物。
{"title":"An open labeled clinical trail on the effect of Vrikshamla\u0000in Sthaulya (obesity) w.s.r to hyperlipidaemia","authors":"Ishwarayya S Mathapati, M. R.","doi":"10.21760/jaims.5.1.4","DOIUrl":"https://doi.org/10.21760/jaims.5.1.4","url":null,"abstract":"Obesity is one of the leading cause for more than 53 diseases and in India around 30 million peoples\u0000are suffering with Sthaulya (obesity), individual habits with stressful life, wrong dietary habits and\u0000sedentary life is the main cause of disease and no satisfactory treatment is available in conventional\u0000system. Hence there is need explore alternative system of Indian medicine like Ayurveda for the\u0000benefits of sufferers Ayurveda dealt this disease as Sthaulya (obesity) under Medoroga (Adipose tissue\u0000disorder) and many treatment modalities have been explained number of drugs in Brahatrayi\u0000(Charaka, Sushruta and Vagbhat) were cited Bhavamishra was the author of Bhavaprakash Nighantu\u0000(Lexicon) which is one of the Laghutrayis (Sharanghadara, Madhavanidhana and Bhavaprakash) text is\u0000highlighted with Karmaoushadi (action based drug) such as Amradi Phala Varga explained Vrikshamla\u0000considered as drug index of Ayurveda, thus present study was designed to screen the drug with\u0000properties of Kapha Medohara (ability to reduce Kapha and Fat), Medorogahara (reduces Adipose\u0000tissue), Sthaulyanashaka (Anti obesity) and Karshyakara (ability to make lean) from Bhavaprakasha\u0000Nighantu in Ayurveda.","PeriodicalId":153289,"journal":{"name":"Journal of Ayurveda and Integrated Medical Sciences (JAIMS)","volume":"85 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114285760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The effect of Dhumpana therapy in comparative studyof Haridra Dhumpana and Behada Dhumvarti in thepreventive management of Tamak Shwasa Dhumpana疗法在Tamak Shwasa预防治疗中的效果比较研究
Pub Date : 2020-02-28 DOI: 10.21760/jaims.5.1.1
Lina S. Tawar, Varsha Jaraje, R. M. Shah, Sushil Navsare
Tamak shwasa is one among the major disease explained in Ayurveda is caused due to infection ofKapha and Vata Dosha in pranvaha Srotas. The condition is analogues to Bronchial asthma asexplained in modern medical science. India has an estimated 15-20 million Asthmatic every year andthe disease occurs at very young age that survey status one in every six child under the age of 16 isaffected. In Ayurveda for management of Tamak shwasa medicines are available and for preventionsome method like Dhumpana, Vamana, Swedan, Virechna, Pratimarshya Nasyakarma. It may help torelive the complaints and prevents further attack. 10 patients were selected for study of Tamakshwasa and divided in two groups. 5 patient in each group. Group A is given Haridra Dhumpana andgroup B is experimental group. Behada Dhumavarti is given to group B.
Tamak shwasa是阿育吠陀解释的主要疾病之一,是由pranvaha Srotas中的kapha和Vata Dosha感染引起的。这种病类似于现代医学所解释的支气管哮喘。据估计,印度每年有1500万至2000万哮喘患者,而且这种疾病发生在很小的年龄,调查显示,每6个16岁以下的儿童中就有1个受到影响。在阿育吠陀,治疗塔玛克舒瓦萨的药物和预防方法是可用的,如Dhumpana、Vamana、瑞典、Virechna、Pratimarshya Nasyakarma。这可能有助于缓解抱怨,防止进一步的攻击。选择10例患者进行Tamakshwasa研究,分为两组。每组5例。A组给药,B组为实验组。B组给予Behada Dhumavarti。
{"title":"The effect of Dhumpana therapy in comparative study\u0000of Haridra Dhumpana and Behada Dhumvarti in the\u0000preventive management of Tamak Shwasa","authors":"Lina S. Tawar, Varsha Jaraje, R. M. Shah, Sushil Navsare","doi":"10.21760/jaims.5.1.1","DOIUrl":"https://doi.org/10.21760/jaims.5.1.1","url":null,"abstract":"Tamak shwasa is one among the major disease explained in Ayurveda is caused due to infection of\u0000Kapha and Vata Dosha in pranvaha Srotas. The condition is analogues to Bronchial asthma as\u0000explained in modern medical science. India has an estimated 15-20 million Asthmatic every year and\u0000the disease occurs at very young age that survey status one in every six child under the age of 16 is\u0000affected. In Ayurveda for management of Tamak shwasa medicines are available and for prevention\u0000some method like Dhumpana, Vamana, Swedan, Virechna, Pratimarshya Nasyakarma. It may help to\u0000relive the complaints and prevents further attack. 10 patients were selected for study of Tamak\u0000shwasa and divided in two groups. 5 patient in each group. Group A is given Haridra Dhumpana and\u0000group B is experimental group. Behada Dhumavarti is given to group B.","PeriodicalId":153289,"journal":{"name":"Journal of Ayurveda and Integrated Medical Sciences (JAIMS)","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125734229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Ayurvedic preparation on stages of labor- A Clinical Study 阿育吠陀制剂对产程影响的临床研究
Pub Date : 2020-02-28 DOI: 10.21760/jaims.5.1.8
P. .
The process of giving birth to young ones is becoming complicated day by day. Different seriousconditions were faced by females during the phenomenon of labor. The present clinical trial is a smallbut an effective effort to facile the complicated process of labor. It aims to reduce the intensity of painwith duration of the labour, to decrease the frequency of caesarean section and application of forcepsat the time of delivery. To facilitate the phenomenon of labor (Sukh-Prasava) Aacharya Charakaindicates the use of Anuvaasana basti and picchu of taila medicated of madhura gan dravyas duringninth month of pregnancy. In this study tila taila murchit by madhura gana dravyas mixed withkwatha of four self assumed (kalpit dravyas) named Sukh-Prasava taila is used for soothing thephenomenon of labor. The 30 patients (Primigravida) were selected randomly, which were givenAnuvaasana basti fortnightly and Picchu daily from the beginning of 9th month till delivery with Sukh-Prasava taila. All routine laboratory investigations were also assessed. The patients treated with Sukh-Prasava taila had shown better results by successfully decreasing the standard mean duration of allthe three stages of labour with intensity of pain.
生孩子的过程一天比一天复杂。女性在分娩过程中面临着不同的严峻状况。目前的临床试验虽小,但为简化复杂的分娩过程作出了有效的努力。它的目的是减少疼痛强度随着分娩的持续时间,减少剖腹产的频率和使用产钳的分娩时间。为了促进分娩现象(Sukh-Prasava), Aacharya charakan指出,在怀孕的第九个月期间,使用Anuvaasana basti和picchu的药物madhura gan dravaya。在这项研究中,由madhura gana dravyas混合的tila taila murchit与名为Sukh-Prasava taila的四种自我假设(kalpit dravyas)混合用于缓解分娩现象。随机选择30例(Primigravida)患者,从第9个月开始,每两周给予anuvaasana basi和Picchu每日给予Sukh-Prasava taila直至分娩。对所有常规实验室调查也进行了评估。用Sukh-Prasava taila治疗的患者成功地减少了所有三个产程的标准平均持续时间和疼痛强度,显示出更好的结果。
{"title":"Effect of Ayurvedic preparation on stages of labor\u0000- A Clinical Study","authors":"P. .","doi":"10.21760/jaims.5.1.8","DOIUrl":"https://doi.org/10.21760/jaims.5.1.8","url":null,"abstract":"The process of giving birth to young ones is becoming complicated day by day. Different serious\u0000conditions were faced by females during the phenomenon of labor. The present clinical trial is a small\u0000but an effective effort to facile the complicated process of labor. It aims to reduce the intensity of pain\u0000with duration of the labour, to decrease the frequency of caesarean section and application of forceps\u0000at the time of delivery. To facilitate the phenomenon of labor (Sukh-Prasava) Aacharya Charaka\u0000indicates the use of Anuvaasana basti and picchu of taila medicated of madhura gan dravyas during\u0000ninth month of pregnancy. In this study tila taila murchit by madhura gana dravyas mixed with\u0000kwatha of four self assumed (kalpit dravyas) named Sukh-Prasava taila is used for soothing the\u0000phenomenon of labor. The 30 patients (Primigravida) were selected randomly, which were given\u0000Anuvaasana basti fortnightly and Picchu daily from the beginning of 9th month till delivery with Sukh-\u0000Prasava taila. All routine laboratory investigations were also assessed. The patients treated with Sukh-\u0000Prasava taila had shown better results by successfully decreasing the standard mean duration of all\u0000the three stages of labour with intensity of pain.","PeriodicalId":153289,"journal":{"name":"Journal of Ayurveda and Integrated Medical Sciences (JAIMS)","volume":"32 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117010833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Ayurveda and Integrated Medical Sciences (JAIMS)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1